Background
- Score for effectively ruling out infective endocarditis that can be used to triage patients with Staphylococcus aureus bacteremia to transesophageal endocarditis or not
Criteria
| Item | Points |
|---|---|
| Cerebral or peripheral emboli | 5 |
| Meningitis | 5 |
| Permanent intracardiac device or previous IE | 4 |
| Preexisting native valve disease | 3 |
| IV drug use | 4 |
| Positive culture after 48 hours | 3 |
| Community or healthcare-associated bacteremia (rather than nosocomial) | 2 |
| Severe sepsis or septic shock | 1 |
| C-reactive protein >190 mg/L | 1 |
- Preexisting native valve disease include any condition classified as medium or high risk1
Interpretation
- Cutoff ≥3
Further Reading
- The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia. J Infect. 2016;72(5):544-53. doi: 10.1016/j.jinf.2016.02.003 The VIRSTA score, a prediction score to estimate risk of infective endocarditis and determine priority for echocardiography in patients with Staphylococcus aureus bacteremia
References
- ^ Adnan S. Dajani, Kathryn A. Taubert, Walter Wilson, Ann F. Bolger, Arnold Bayer, Patricia Ferrieri, Michael H. Gewitz, Stanford T. Shulman, Soraya Nouri, Jane W. Newburger, Cecilia Hutton, Thomas J. Pallasch, Tommy W. Gage, Matthew E. Levison, Georges Peter, Gregory Zuccaro. Prevention of Bacterial Endocarditis: Recommendations by the American Heart Association. The Journal of the American Dental Association. 1997;128(8):1142-1151. doi:10.14219/jada.archive.1997.0375.
